Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease--research or clinical application?
Department of Child Health, King's College School of Medicine and Dentistry, London, United Kingdom.
- Published Article
European journal of pediatrics
- Publication Date
Jan 01, 1995
8 Suppl 3
Research studies have highlighted both physiological and pathological evidence to incriminate surfactant abnormality and/or deficiency in many neonatal respiratory diseases. Data from animal models and clinical studies support the concept that surfactant replacement therapy (SRT) may have a role to play in such problems. There is now, therefore, a need to perform further randomized controlled trials to assess the appropriate clinical application of SRT in non-respiratory distress syndrome neonatal respiratory disease.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 04/09/2020 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/7588985